Technology, Information, and Service for Life Science@ CareTIS, Co., Ltd.

HOME ABOUT CARETIS CORE TECHNOLOGY BUSINESS SOLUTION SERVICES CONTACT US

HOME (TOP)

ABOUT Caretis

CORE TECHNOLOGY

BUSINESS SOLUTION

SERVICES

CONTACT US


Core Technology/seeds

yRepresentativez@Kazuhiko Sakata,@Ph.D

yThe main branchz2-1-6 Kazusakamatari Kisarazu-shi Chiba-ken, Japan, 292-0818

yTelz{81-(0)438-52-3112 @@
yFaxz{81-(0)438-52-2132

yURLz@http://www.caretis.co.jp
ye-mailz info@caretis.co.jp
yResearch interestsz
@1.Development of gHigh sensitivity/easy-handlingh diagnosis products.
@2.Drug discovery (stroke, cancer, allergy)

@Caretis is a bio-venture company aiming at creating a new business to perform gpreventive medicineh by fusing a gdiagnosis/inspection productsh and gdrug@discoveryh@functionally.

Our interesting targets are hypoxia istroke and cancer) and allergic diseases.

1. Innovative diagnosis technology
@We have technology (high sensitivity antigen detection technology: Immuno-PCR) to detect an antigen(biomarker) using an antibody. This technology has 1,000 times higher sensitivity than a general-purpose method. This kit(the brand name is gimTag@PCRh) is also commercialized. We are developing the most suitable device and products in order to utilize these technologies in bedsides and clinical inspection rooms. In addition, we identify a marker of a cerebrovascular disease (stroke) and the protein which is specific for cancer metastasis and angiogenesis.

2. Drug discovery seeds
@We develop candidates of drug for ischemia-related diseases. One of these candidates is the material which is effective for a cerebrovascular accident and myocardial infarction (by animal experiment) caused by an ischemia. And we also have anti-allergic compounds library and high through-put screening systems.

3. Other products
@We produce and sell the inspection kits(a kit measuring pollen, mold/bacteria, quantity of allergen of a mite: the first two kits are original worldwide) which inspect indoor environment for quantity of allergens. We regard them as promotion items in each fields, we are planning the expansion of distribution channel and usage.